Substituted benzazoles and use thereof as inhibitors of Raf kinase

Details for Australian Patent Application No. 2004277405 (hide)

Owner Chiron Corporation

Inventors Ramurthy, Savithri; Amiri, Payman; Poon, Daniel J.; Subramanian, Sharadha; Renhowe, Paul A.; Sung, Leonard; Fantl, Wendy; Levine, Barry Haskell

Agent FB Rice

Pub. Number AU-A-2004277405

PCT Pub. Number WO2005/032548

Priority 10/675,927 29.09.03 US

Filing date 29 September 2004

Wipo publication date 14 April 2005

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/032548 Priority application(s): WO2005/032548

26 June 2008 Assignment before Grant

  Chiron Corporation The application has been assigned to Novartis Vaccines and Diagnostics, Inc.

5 November 2009 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277414-Penile prosthesis devices

2004277403-Polybiotin compounds for magnetic resonance imagining and drug delivery